Quantcast
Home > Quotes > ENZ

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (ENZ) Quote & Summary Data

ENZ 
$4.02
*  
0.02
0.5%
Get ENZ Alerts
*Delayed - data as of Aug. 16, 2018 14:37 ET  -  Find a broker to begin trading ENZ now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    ENZ Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
12
Today's High / Low
$ 4.11 / $ 4.005
Share Volume
31,398
90 Day Avg. Daily Volume
168,084
Previous Close
$ 4
52 Week High / Low
$ 11.50 / $ 3.95
Market Cap
189,607,087
P/E Ratio
NE
Forward P/E (1y)
Earnings Per Share (EPS)
$ -0.09
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.43

Intraday Chart

Shares Traded

Share Volume:
31,398
90 Day Avg. Daily Volume:
168,084

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.09

Trading Range

The current last sale of $4.02 is 1.77% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 4.11 $ 11.50
 Low: $ 4.005 $ 3.95

Company Description (as filed with the SEC)

Enzo Biochem, Inc. (the "Company" "we", "our" or "Enzo") is an integrated diagnostic bioscience company focusing on delivering and applying advanced technology capabilities to produce affordable reliable products and services to allow our customers to meet their clinical needs. We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. Enzo's structure and business strategy represent the culmination of years of extensive planning and work. The Company now has the unique ability to offer low cost, high performance products and services in molecular diagnostics, which ideally positions it to capitalize on the reimbursement pressures facing diagnostic labs.  ... More ...  


Risk Grade

Where does ENZ fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info